Staff

Dr. Vishal Navani

Principal Director

Dr. Navani received his Masters in Medical Sciences from Oxford and Medical Degree from Imperial College London. He subsequently completed internal medicine residency in Sydney, Australia and medical oncology fellowship training in Newcastle, Australia and the Tom Baker Cancer Centre, Calgary, Alberta.

His academic focus includes the interrogation of large real world datasets spanning tumour streams in order to generate practical insights that can be used in the clinic. He is due to start a staff position as a medical oncologist focusing on thoracic and genitourinary malignancies at the Tom Baker Cancer Centre in 2022. He joined Glans-Look in 2022 to provide clinical and scientific oversight, and became Principal Director in 2023.

Dr. Winson Cheung

Director Emeritus

Dr. Winson Y. Cheung, MD, MPH, is a senior medical oncologist and real-world data scientist with over 15 years of cancer research experience. He is currently a Full Professor in the Departments of Oncology, Medicine, and Community Health Sciences at the University of Calgary where he is also the Provincial Director and Chair of the Health Services Research and Real-World Evidence (RWE) Generation Program at Cancer Care Alberta. Dr. Cheung’s main research interest is health outcomes research and RWE generation across all cancer types, including solid tumors and hematologic malignancies. He has cultivated strong and effective partnerships with public and private sectors. In addition to being the Principal Director of the Glans-Look Lung Cancer Research Program, he is the Principal Director of the Oncology Outcomes (O2) Program that focuses on enriching data sources and leveraging new technologies to facilitate “fit-for-purpose” cancer RWE generation. Dr. Cheung’s track record in the RWE space includes invitations to over 100 presentations, more than 200 peer-reviewed scientific manuscripts, and the receipt of more than $10 million in competitive grant funding. He acts as the chief sounding board for projects using cancer data and serves as the preferred point of first contact for oncology RWE queries in Alberta.

Michelle Dean

Research Program Manager

Michelle Dean, a University of Calgary alumnus (B.Sc. Biological Sciences, B.Sc. Primatology), has over 18 years of research experience within the Cumming School of Medicine and Arnie Charbonneau Cancer Institute. She joined the Glans-Look Research team as a study coordinator in 2017 and became Program Manager in 2021.

In this role, Michelle oversees quality improvement initiatives and drives cross-functional collaborations with industry partners, patient advocacy groups, and research initiatives. As a key liaison between multidisciplinary teams, she facilitates research integration, data sharing, and clinical software development for the Glans-Look database.

Her work facilitates identifying actionable biomarkers using program-collected metrics to predict clinical outcomes, contributing to the advancement of personalized treatment strategies in lung cancer care.

Amanda Gibson

Project Team Lead & Data Specialist

Amanda graduated from the University of Calgary with a B.Sc (Hons) Ecology, and began her career with the (former) Alberta Cancer Board as a Research Assistant. She joined the Glans-Look Research program 2016, expanding her role to involve the design and revision of the Glans-Look Lung Cancer database to adapt to the expanding role of precision/personalized medicine in the management of lung cancer, and project design which focuses on translational real-world evidence generation using the research-grade data within the Glans-Look Lung Cancer database.

Dr. Gwyn Bebb

Founding Director

Dr. Gwyn Bebb is a Medical Oncologist who practiced at the Tom Baker Cancer Centre (Calgary, AB) with a clinical focus in the treatment of lung malignancies. As Associate Professor of Medicine with The University of Calgary, he mentored graduate students, medical students, residents and other healthcare professionals until his departure in 2021.

Dr. Bebb received his undergraduate degree in Cambridge, UK in 1983, his medical degree in Oxford, UK in 1992 and PhD at UBC. After completing his Internal Medicine and Medical Oncology training in Vancouver he was awarded a CAMO fellowship to research “Targeted Therapy in new mouse models of Mantle Cell Lymphoma”. He has also held the director role for the Clinical Trials Unit at the Tom Baker Cancer Centre and led a basic science lab at the University of Calgary’s Cumming School of Medicine / Robson DNA Science Network.